Lauren Stival | Investor Relations, Stern Investor Relations, Inc. |
Douglas Fambrough | President and Chief Executive Officer |
Jack Green | Chief Financial Officer |
James Weissman | Chief Operating Officer and Executive Vice President |
Ralf Rosskamp | Chief Medical Officer |
Ed Arce | H.C. Wainwright & Co. |
Umer Raffat | Evercore ISI |
Brendan Smith | Cowen and Company |
Stephen Willey | Stifel Nicolaus |
Aravinda Kuntimaddi | SVB Leerink |
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request.
I will now turn the call over to your host, Lauren Stival representing Dicerna Pharmaceuticals.